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Complex membrane structures induced by
West Nile virus (WNV), an enveloped RNA virus,
are required for efficient viral replication. How
these membranes are induced and how they
facilitate the viral life cycle are unknown. We
show that WNV modulates host cell cholesterol
homeostasis by upregulating cholesterol bio-
synthesis and redistributing cholesterol to viral
replication membranes. Manipulating choles-
terol levels and altering concentrations of cellu-
lar geranylgeranylated proteins had a deleteri-
ous effect on virus replication. Depletion of the
key cholesterol-synthesizing enzyme 3-hy-
droxy-methyglutaryl-CoA reductase drastically
hampered virus replication. Significantly, virus-
induced redistribution of cellular cholesterol
downregulated the interferon-stimulated Jak-
STAT antiviral signaling response to infection.
This defect could be partially restored by exog-
enous addition of cholesterol, which increased
the ability of infected cells to respond to inter-
feron.We propose that, bymanipulating cellular
cholesterol, WNV utilizes the cellular response
to cholesterol deficiency and dependence of
antiviral signaling pathways on cholesterol-
rich microdomains to facilitate viral replication
and survival.
INTRODUCTION
The Flaviviridae are a family of highly pathogenic, small,
enveloped RNA viruses that cause a range of infections
in man, for example, yellow fever, encephalitis, dengue
(by species of the Flavivirus genus), and hepatitis C (by
hepatitis C virus [HCV], a species within the hepacivirus
genus). Hundreds of thousands of deaths associated
with flavivirus infections occur each year, many of which
are unpreventable with current vaccine and therapeutic
strategies. The recent emergence and spread of WestCell Host &Nile virus New York 99 (WNVNY99) strains within North
America has also presented a considerable concern, as
24,734 cases with 920 fatalities have been reported since
1999. The prevalence of HCV is also increasing, and liver
cirrhosis and carcinoma, pathological outcomes of HCV
infection, are likewise on the increase.
Like all viruses, flaviviruses exploit the cellular machin-
ery to facilitate propagation of infectious progeny virions.
An Australian strain of WNV virus, Kunjin (WNVKUN) repre-
sents one of the best studied models of intracellular
changes induced by flavivirus infections. During the infec-
tion process highly complex membrane structures are
induced, which act as platforms for viral replication (Mack-
enzie et al., 1999; Westaway et al., 2002). How these
membranes facilitate viral RNA replication and virion
assembly and the virus-cell interactions involved in induc-
ing these specialized membrane subdomains are cur-
rently unknown (Mackenzie, 2005). In addition to utilizing
the cellular machinery for replication, viruses must also
disable and/or circumvent the cellular immune response.
A key mediator of our host defense against pathogens is
the interferon response. During viral infection this
response is triggered by recognition of viral products by
pattern recognition receptors (Akira et al., 2006; Basler
and Garcia-Sastre, 2007; van Boxel-Dezaire et al.,
2006). This recognition leads to cascade of signaling
events including the activation of transcription factors
involved in induction of expression of IFN-a/b. Secreted
IFN-a/b then binds to specific cell surface receptors to
initiate signaling cascade via the Jak-STAT pathway, cul-
minating in the production of a wide range of antiviral
products (Akira et al., 2006; Garcia-Sastre and Biron,
2006). Like many viruses, flaviviruses can combat IFN-a/b
signaling, primarily by interfering with the activation of
Jak-STAT pathway (Guo et al., 2005; Jones et al., 2005;
Lin et al., 2004; Liu et al., 2005; Munoz-Jordan et al.,
2003). A number of flavivirus proteins have been impli-
cated in inhibition of IFN signaling, although different flavi-
viruses appear to utilize different viral proteins for this pur-
pose (Best et al., 2005; Lin et al., 2006; Liu et al., 2005;
Munoz-Jordan et al., 2003, 2005). However, why different
viral proteins from different flaviviruses are required to
perform the same function and what the mechanism of
this inhibition is are not clear.Microbe 2, 229–239, October 2007 ª2007 Elsevier Inc. 229
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Modulation of Cholesterol by FlavivirusesIn vertebrate cells cholesterol homeostasis is tightly
regulated in a feedback mechanism via transcriptional
factors that sense intracellular cholesterol levels (Adams
et al., 2003; Brown et al., 2002; Brown and Goldstein,
1997; Goldstein et al., 2006; Horton et al., 2002; Nohturfft
et al., 2000; Radhakrishnan et al., 2007; Sun et al., 2007).
These transcription factors are termed sterol-regulatory
element-binding proteins (SREBPs) that associate tightly
with the sterol-sensing protein SREBP cleavage-activat-
ing protein (SCAP) within the ER membrane, via an ad-
ditional interaction with the ER resident protein Insig.
SCAP has an additional role as an escort protein that
mediates transport of the SREBP-SCAP complex to the
Golgi apparatus where SREBP is proteolytically cleaved
by two resident Golgi proteases (S1P and S2P) to release
the transcriptionally active form of SREBP from the mem-
brane. The released form of SREBP is transported to the
nucleus and activates transcription of target genes re-
quired for cholesterol biosynthesis, including HMGCR
and fatty acid synthase. When cholesterol levels are
high, SCAP binds to cholesterol in the ER, promoting an
association with Insig, retaining the complex within the
ER, thus reducing the synthesis of cholesterol. Con-
versely, when cholesterol levels are low, binding of
SCAP to Insig is disrupted, and cholesterol metabolism
is initiated. As the virus-inducedmembranes show similar-
ities to membranes induced upon perturbation of choles-
terol-synthesizing enzymes (Orci et al., 1984), we specu-
lated that changes in cholesterol could underlie the
cellular changes occurring upon viral infection.
RESULTS
WNV Infection Leads to a Redistribution
of Cholesterol and Cholesterol-Synthesizing
Proteins to the Sites of Virus Replication
We first examined the intracellular distribution of choles-
terol in control and WNVKUN-infected cells using filipin as
a marker of unesterified cholesterol. Filipin stained the
plasma membrane and internal organelles of mock-
infected cells (Figures 1Ac and 1Ad), but this distribution
was markedly different in WNVKUN-infected cells (Fig-
ure 1Ab). Infection of cells withWNVKUN led to amore con-
fined perinuclear localization of filipin-bound cholesterol
and a dramatic loss of cholesterol staining at the plasma
membrane (indicated by arrowheads in Figures 1Ac and
1Ad). Perinuclear foci detected with filipin also coincided
with those stained with virus-specific anti-dsRNA anti-
bodies (compare Figures 1Aa and 1Ab). Thus, WNVKUN
appears to coordinate a redistribution of cellular choles-
terol to the sites of virus replication.
We next examined the possible role of the key choles-
terol-synthesizing enzyme, 3-hydroxy-methyglutaryl-CoA
reductase (HMGCR), in WNVKUN replication. HMGCR is
required for the synthesis of mevalonate, a precursor for
isoprenoids and cholesterol, and is upregulated in re-
sponse to cholesterol depletion or degraded in response
to high sterol levels (Goldstein and Brown, 1990). Addi-
tionally, overexpression of HMGCR during compactin230 Cell Host & Microbe 2, 229–239, October 2007 ª2007 Elsevtreatment resulted in the proliferation and induction of
reticular membranes visually similar to those observed
during flavivirus infection (Anderson et al., 1983; Orci
et al., 1984). Expression of HMGCR was induced 3- and
5-fold after 24 hr of infection of Vero cells with either
WNVNY99 orWNVKUN, respectively (Figure 1B). In addition,
immunofluorescence (IF) analysis indicated that a signifi-
cant pool of HMGCR was confined to the large cytoplas-
mic foci recognized by antibodies directed against the
WNVKUN nonstructural protein NS1 in both WNVNY99-
and WNVKUN-infected cells (Figure 1C). This was further
confirmed by immunolabeling of thawed cryosections
from WNVKUN-infected cells where anti-HMGCR labeling
was associated with the virus-induced convoluted-mem-
brane (CM) structures (Figure 1D, quantitation analysis in
Figure S2 in the Supplemental Data available with this
article online). These observations suggest a role for
HMGCR and cholesterol in establishing membrane plat-
forms required for efficient WNV replication. The localiza-
tion of HMGCR within proliferated reticulum membranes
in infected cells also implicates a possible role for HMGCR
in the biogenesis of these membrane platforms, poten-
tially via the virus-induced relocation of cellular cholesterol
pools in concert with the WNVKUN NS4A protein, previ-
ously shown to proliferate internal membranes (Roosen-
daal et al., 2006).
Changes in Cholesterol Biosynthesis
and/or Trafficking Affect WNV RNA Replication
To determine whether the observed redistribution of
cholesterol (Figure 1A) was essential for WNV replication,
we used aWNVKUN replicon encoding the reporter protein
b-galactosidase in conjunction with treatments that affect
cholesterol biosynthesis (see Table S1). We have shown
previously that b-galactosidase expression in this system
correlates well with WNVKUN replicon RNA replication
efficiency (Liu et al., 2002). To dissect the role of HMGCR
during WNV infection, we utilized treatments that directly
modulate HMGCR activity (namely the HMGCR inhibitor
lovastatin [Lov]) and that affect the level of cellular choles-
terol (methyl-b-cyclodextran [M-b-CD]) or the processing
of cholesterol transcription factors (25-hydroxycholesterol
[25-HC]; Wang et al., 1994). In addition, we increased cho-
lesterol levels by the addition of exogenous cholesterol.
Addition of Lov, 25-HC, or cholesterol itself to the culture
medium had deleterious effects on replicon RNA replica-
tion (48%, 30%, and 59% decreases, respectively; see
Figure 2A). Interestingly, a greater synergistic effect was
observed when Lov and cholesterol were added together.
In this case replicon replication was decreased by 89%.
All of these observed effects were also reflected in
decreases in virus replication (Figures 3A and 3B), the pro-
duction of infectious virus (Figure 3C), and the formation of
the virus-induced membrane structures when assessed
on WNVKUN-infected cells (Figure 3D). The observed
effects of the cholesterol-modulating compounds ap-
peared specific for WNVKUN replication, as similar treat-
ments of cells transfected with a Semliki Forest virus (SFV)
replicon expressing the b-galactosidase gene showedier Inc.
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Modulation of Cholesterol by FlavivirusesFigure 1. Infection of Mammalian Cells with WNV Redistributes Intracellular Cholesterol and HMGCR to the Sites of Virus
Replication
Vero cells infected with WNVKUN for 24 hr were stained with the cholesterol-binding compound filipin (Aa–Ac) and viewed by fluorescence micros-
copy. A drastic decrease in the amount of cholesterol at the plasma membrane is observed when compared to uninfected cells (arrowheads in [Ae]
and [Af]), with an associated increase of cholesterol staining in the perinuclear area of the infected cells (arrows in [Aa]–[Ab]) with a majority coloc-
alizing with virus replication sites immunostained with antibodies to anti-dsRNA (Aa). For ease of visualization, the filipin staining was imported
into the green channel during processing in Adobe Photoshop software, and a yellow hue in (Ac) indicates overlap of the anti-dsRNA and filipin stain-
ing. (B) Western blot analysis of lysates prepared from mock-, WNVKUN-, or WNVNY99-infected cells indicated that HMGCR protein expression was
upregulated during virus infection. Subcellular localization studies revealed that a majority of the HMGCR protein accumulated within virus-induced
membrane structures, as assessed by IF analysis (C) with rabbit antibodies specific to HMGCR visualized with anti-rabbit Oregon green and mouse
antibodies to WNV NS1 visualized with anti-mouse Texas red. Colocalization is observed as a yellow hue in the right-hand panels. Additionally, im-
munolabeling of thawed cryosections from WNVKUN-infected cells with antibodies specific to HMGCR (D) clearly indicated accumulation within the
virus-induced CM structures. Abbreviations in (D): CM, convoluted membranes; VP, vesicle packets. Scale bars, 200 nm.different effects on SFV replication (Figure S1A). For
example, treatment of SFV-transfected cells with choles-
terol had no effect on SFV replication, whereas treatment
with Lov increased SFV replication by 100% (Figure
S1A). These observations demonstrate specific inhibitory
effects of the cholesterol-modulating drugs on WNV repli-
cation. Additionally, only minor cytotoxic effects were
observed when transfected or mock-infected cells were
incubated with the cholesterol compounds (Figures S1BCell Hostand S1C). Taken together, these results suggest that viral
infection causes redistribution of intracellular cholesterol
and an associated upregulation of HMGCR and imply
that WNV replication is dependent on HMGCR activity.
The corresponding influence of HMGCR on virus replica-
tion appears to be tightly linked to efficient viral replication
and induction of virus-induced membrane platforms. We
have previously shown that efficient WNVKUN is intimately
linked with membrane induction (Mackenzie et al., 2001).& Microbe 2, 229–239, October 2007 ª2007 Elsevier Inc. 231
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Modulation of Cholesterol by FlavivirusesFigure 2. WNVKUN Replication Is Depen-
dent on HMGCR Activity, Implicating
a Role for Both Cholesterol and Geranyl-
geranylated Host Proteins during
Replication
(A) Quantification of the observed effects of
lovastatin, M-b-CD, cholesterol, 25-hydroxy-
cholesterol, and a combination of lovastatin
and cholesterol on WNVKUN replicon RNA rep-
lication. Addition of lovastatin (**p < 0.0001,
Student’s t test), cholesterol (**p < 0.0001, Stu-
dent’s t test), and 25-hydroxycholesterol (*p <
0.002, Student’s t test) all efficiently reduced
replication of the replicon RNA, whereas the
combination of lovastatin and cholesterol
(**p < 0.0001, Student’s t test) had a greater
synergistic effect on the replicon replication.
(B and C) Quantification of the effect of gera-
nylgeranylation inhibitors onWNVRNA replica-
tion. The geranylgeranylation inhibitor GGTI
had a marked effect on replicon replication
(**p < 0.0001, Student’s t test), whereas the
farnesylation inhibitor FPTI had no effect on
replication (not significant). The role for gera-
nylgeranylation was further substantiated, as
addition of geranyl-phosphate could partially
rescue the observed replicon replication inhibi-
tion by lovastatin (**p < 0.0001, Student’s t
test), whereas the addition of farnesyl-phos-
phate was less effective (*p < 0.01, Student’s
t test).
(D) AY-9944 treatment dramatically impaired
WNVKUN RNA replication (**p < 0.0001, Stu-
dent’s t test), establishing a strict requirement
for both cholesterol and geranylgeranylation
during efficient replication.
(E) RNAi-mediated knockdown of the HMGCR
gene efficiently reduced WNVKUN replicon
replication (**p < 0.0001, Student’s t test).
The western blot indicates that expression of
the HMGCR protein was effectively reduced
by the RNAi treatment but not with a control
(con) RNAi.The role for HMGCR during viral membrane formation is
exemplified by the profound effects of cholesterol and
Lov addition, whereby the induction of viral membranes
is hampered (Figure 3D) and correspondingly reduces
virus replication. This is in contrast to the recent report
indicating that HCV RNA was retained within
membranous structures in the presence of cholesterol in-
hibitors (Sagan et al., 2006). WNV replication complex is
derived from trans-Golgi membranes, and the HCV repli-
cation complex is derived from ER membranes; thus,
the effects of cholesterol-modulating drugs on the com-
position of these two different cellular membranes modi-
fied by virus infection may be different. Exogenous addi-
tion of cholesterol was previously observed to lead to
dissolution of HMGCR-induced membrane proliferation
(Anderson et al., 1983), correlating with our observations
presented here.
An additional effect of HMGCR upregulation is to
increase synthesis of prenylated (geranylgeranylated
and farnesylated) proteins. Previous investigations have232 Cell Host & Microbe 2, 229–239, October 2007 ª2007 Elsevreported that the observed deleterious effects of Lov on
HCV replicon replication (Sagan et al., 2006; Ye et al.,
2003) involved geranylgeranylation of the host protein
FBL2 (Wang et al., 2005). To investigate whether WNV
replication was dependent on prenylation, we assessed
WNVKUN replicon replication in the presence of inhibitors
of protein geranylgeranylation and farnesylation. WNVKUN
replicon RNA replication was unaffected in the presence
of an inhibitor of farnesylation (FPTI) but was significantly
impaired in the presence of the geranylgeranylation inhib-
itor GGTI (decreased to approximately 24% of untreated
controls; Figure 2B). Inhibition of WNVKUN replicon repli-
cation imposed to some extent by the prevention of preny-
lation modification induced by Lov treatment (Figures 2A
and 2C) could be partially restored by the addition of
geranyl-pyrophosphate (Lov + GPO; to approximately
60% of untreated levels) and to some extent by the addi-
tion of farnesyl-pyrophosphate (Lov + FPO; 34% of
untreated levels) (Figure 2C). As HMGCR-mediated mod-
ification of prenylated proteins occurs before theier Inc.
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Modulation of Cholesterol by FlavivirusesFigure 3. Modulation of HMGCR Activity and Cholesterol Biosynthesis Has Deleterious Effects on WNVKUN Virus Production
(A) WNVKUN-infected Vero cells were treated with the appropriate drugs for 22.5 hr, at which point the infected lysates were harvested for protein
analysis by western blotting for the WNVKUN protein NS5, and the host protein actin was used as a loading control.
(B) The relative expression of the NS5 protein was quantified by normalizing its expression based on the expression of the host protein actin.
(C) Tissue culture fluid was harvested from treated and WNV-infected cells to assess the production of infectious virus particles upon treatment with
the appropriate drugs. Statistical analysis: *p < 0.05, Student’s t test.
(D) Formation of viral membrane platforms associated with viral replication is regulated by HMGCR activity. WNVKUN-infected cells were treatedwith
the appropriate concentration of drugs for 22.5 hr and subsequently assessed for virus-inducedmembrane formation by IF. Subcellular localization of
WNVKUN NS3 was identified by immunostaining with rabbit mono-specific antibodies and visualized with rabbit-specific IgG conjugated to Oregon
green.synthesis of cholesterol, we sought to address whether
the observed Lov-induced defects were only due to the re-
duction in available geranylgeranylated proteins or also
due to the production of cholesterol itself. For these
analyses we took advantage of a drug, AY-9944, that
specifically blocks the host enzyme 7-dehydrocholesterol
D7-reductase responsible for the final conversion step of
7-dehydrocholesterol to cholesterol (Kolf-Clauw et al.,
1996). Addition of AY-9944 dramatically decreased the
replication efficiency of the WNVKUN replicon (Figure 2D)
to levels equivalent to that observed with GGTI. In addi-
tion, RNAi knockdown of the HMGCR gene resulted in
a significant reduction in WNVKUN RNA replication (Fig-Cell Houre 2E). These results suggest that the replication of
WNVKUN shows a strict requirement for both intracellular
cholesterol and geranylgeranylated host proteins that
depends on the expression and activity of HMGCR.
WNV Infection Severely Compromises Formation
of Cholesterol-Rich Microdomains and Their
Function in Activation of Interferon Signaling
In view of the redistribution of cholesterol from the plasma
membrane in response to WNV infection (Figure 1), we
speculated that cellular cholesterol-dependent processes
may be affected, including the formation of cholesterol-
richmicrodomains (or lipid rafts) at the plasmamembrane.st & Microbe 2, 229–239, October 2007 ª2007 Elsevier Inc. 233
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Modulation of Cholesterol by FlavivirusesWe hypothesized that such modulation may regulate the
interferon (IFN)-mediated response to WNVKUN infection.
We first tested whether the formation of cholesterol-de-
pendent surface microdomains was affected upon viral
infection. As an indicator of surface cholesterol disruption,
we assayed association of caveolin-1 (Cav1) with deter-
gent-resistant membranes (DRMs). Cav1 was concen-
trated in DRMs in mock-infected cells (Figure 4A) but
was absent in DRMs isolated fromWNVKUN-infected cells.
Instead, Cav1 was primarily associated with heavy frac-
tions containing the WNVKUN protein NS5 (Figure 4A).
These observations are consistent with disruption of
cholesterol-dependent lipid raft domains.
We next examined whether the observed disruption of
cholesterol-rich microdomains was associated with the
lack of Stat protein phosphorylation observed during flavi-
virus infection (Best et al., 2005; Lin et al., 2004, 2006; Liu
et al., 2005; Munoz-Jordan et al., 2003). Localization of
Stat proteins 3, 5, and 6 within cholesterol-rich microdo-
mains has been documented (Maziere et al., 2001; Sehgal
et al., 2002; Shah et al., 2002), but the association of IFN-
stimulated Stat-1 and Stat-2 proteins has not been so well
described (Marchetti et al., 2006; Sehgal, 2003). Thus, we
utilized three independent assays to assess the role of
cholesterol in facilitating effective intracellular signaling
via the interferon receptor. Depletion or binding of choles-
terol at the plasma membrane with M-b-CD or filipin
severely hampered efficient phosphorylation and nuclear
translocation of Stat-1 protein in response to IFN-a stimu-
lation and impaired transcription of a transfected reporter
plasmid encoding the firefly luciferase gene under control
of an interferon-stimulated responsive element (ISRE;
King and Goodbourn, 1994) (Figures 4B–4D). In all cases
this impairment could be partially rescued with the exog-
enous addition of cholesterol (Figures 4D and 4E), strongly
implying a direct involvement of cholesterol in these
processes.
In view of these results and the dramatic effect of the
virus on cholesterol distribution (Figure 1), we tested the
possibility that virus-mediated inhibition of interferon sig-
naling was due, in part, to an effect on surface cholesterol
levels. If so, we would predict that inhibition of signaling
pathways during virus infection should be rescued by
cholesterol addition. As shown in Figure 5, using two inde-
pendent assays we could show that Stat-1 phosphoryla-
tion and translocation to the nucleus was inhibited in
WNVKUN-infected cells in the presence of IFN-a, and the
majority of Stat-1 was not phosphorylated and remained
within the cytoplasm (Figures 5B and 5D). However, addi-
tion of cholesterol prior to, and during, IFN stimulation
resulted in substantial rescue of Stat-1 phosphorylation
(Figure 5D) and a striking 3-fold increase in nuclear
accumulation of Stat-1 protein (arrows in Figure 5B; quan-
titation in Figure 5C). This can be attributed to the replen-
ishment of cholesterol at the plasma membrane in
WNVKUN-infected cells during incubation with exogenous
cholesterol (Figure 5E). We could also show that the
replenishment of cholesterol-rich microdomains and the
dissolution of the WNV membranous replication complex234 Cell Host & Microbe 2, 229–239, October 2007 ª2007 Elsevin infected cells upon incubation with exogenous choles-
terol (Figure 5E and Figure 3, respectively) have accord-
ingly increased the ability of infected cells to respond to
the antiviral effects of IFN-a (Figure 6). In the presence
of both Chol and IFN, WNV RNA replication was signifi-
cantly impaired by restored IFN-mediated signaling and
by the negative regulation of cholesterol biosynthesis.
These results provide compelling evidence to support
the hypothesis that the observed redistribution of choles-
terol causes disruption of cholesterol-rich microdomain
function and disables the ability of cells to respond to
IFN-mediated stimulation upon WNVKUN infection.
DISCUSSION
Our results show that WNV directly manipulates the host
cell pathway involved in cholesterol biosynthesis in order
to facilitate both virus replication and viral evasion from
the cellular antiviral response. Our observations indicate
that WNV manipulates the intracellular distribution of
cholesterol from the plasma membrane to membranous
sites of virus replication. We hypothesize that upon rep-
lication WNVKUN redistributes intracellular cholesterol
pools (presumably from the plasma membrane) to the
sites of virus replication. This relocation of intracellular
cholesterol (away from sites normally harboring choles-
terol sensory molecules, such as the SREBP-Insig com-
plex) triggers the cell’s natural response to reduced
cholesterol levels. The associated upregulated expression
of HMGCR leads to an increase in cholesterol and geranyl-
geranylated protein biosynthesis and proliferation of intra-
cellular membranes. The expression of HMGCR is tightly
regulated at the transcriptional level via the nuclear import
of the posttranslationally cleaved SREBP-2 protein. The
proteolysis of SREBP-2 occurs in the Golgi apparatus,
and transport of SREBP-2 only occurs when sterol levels
are low via dissociation of the SREBP complex from the
ER-retained Insig molecule. Therefore, our observations
that HMGCR is upregulated in infected cells strongly sug-
gest that cholesterol homeostasis and distribution have
been affected. Overexpression of HMGCR is known to
induce the proliferation of intracellular membranes (Orci
et al., 1984) similar to that observed duringWNVKUN infec-
tion, andwe speculate that HMGCRmay play a synergistic
role with WNVKUN NS4A (Roosendaal et al., 2006) in the
induction of viral-induced membranes. We envision that
the increasedmembrane platform aids the virus by provid-
ing a larger surface area for viral protein production and
virion formation. However, the replenishment of choles-
terol appears to direct cholesterol to the ‘‘correct’’ intra-
cellular location where the increased presence of sterol
induces Insig binding to SREBP, thereby facilitating its
retention within the ER (Goldstein and Brown, 1990; Sun
et al., 2005; Yang et al., 2002). The retention of SREBP-
Insig within the ER is a negative regulator of HMGCR
synthesis and thus mevalonate biosynthesis. This accord-
ingly has a detrimental effect on virus replication through
the reduced levels of cholesterol and geranylgeranylated
proteins and reduced levels of HMGCR contributing toier Inc.
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Modulation of Cholesterol by FlavivirusesFigure 4. Redistribution of Intracellular Cholesterol in WNVKUN-Infected Cells Leads to a Loss of Lipid Raft Function
(A) Western blot and sucrose flotation analysis of caveolin-1 within detergent resistant membranes isolated from mock- and WNVKUN-infected cells
reveals that the ability of caveolin-1 to float within the gradient from infected cells is impaired.
(B) Western blotting for phosphorylated-Stat-1 protein after treatment of cells with cholesterol or M-b-CD and filipin and subsequent stimulation with
interferon-a reveals a dependency on cholesterol-rich microdomains for efficient IFN signaling.
(C) Activation of interferon-stimulated regulatory element (ISRE)-driven transcription is shown as induction of luciferase expression in IFNa-stimulated
cells treated or untreated with the cholesterol depleting agents M-b-CD and filipin.
(D) Nuclear translocation of Stat-1 protein was significantly impaired in the presence of M-b-CD, as assessed by IF analysis, but could be rescued by
cotreatment with cholesterol.
(E) These results were quantified after triplicate experiments in both Vero and A549 cells.membrane induction. In considering this model it is impor-
tant to highlight that the natural vector of flavivirus infec-
tion, the mosquito, is a cholesterol auxotroph and cannotCell Hossynthesize cholesterol. However, mosquito survival is
dependent on cholesterol, and this dietary need is
acquired through the blood meal. Insects still contain allt & Microbe 2, 229–239, October 2007 ª2007 Elsevier Inc. 235
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Modulation of Cholesterol by FlavivirusesFigure 5. Addition of Cholesterol Can Rescue Stat-1 Nuclear Translocation and Phosphorylation in Response to IFN-a in WNVKUN-
Infected Cells
Nuclear translocation of Stat-1 occurred efficiently in uninfected cells in response to IFN-a stimulation but was impaired under similar conditions in
WNVKUN-infected cells (A and B). The translocation defect could be partially rescued upon incubation of WNVKUN-infected cells with cholesterol and
IFN-a (compare arrows in [Be] and [Bh]) as quantified in (C) after triplicate experiments in Vero and A549 cells. The ability of cholesterol to rescue
interferon-mediated signaling was also reflected in the phosphorylation status of Stat-1 upon IFN-a treatment (D). (E) Exogenous addition of choles-
terol to WNVKUN-infected cells restores cholesterol concentration at the plasma membrane. Filipin staining at the plasma membrane is now clearly
evident in the infected cells during incubation with cholesterol.of the enzymes require to metabolize cholesterol and also
encode an HMGCR protein for the production for preny-
lated proteins (Belles et al., 2005). Thus, it is intriguing to
consider these traits between the vector hosts (mosquito)
and the dead-end host (humans). Comparisons between
mammalian and insect cells will be part of our ongoing
studies in this area.
We propose that the redistribution of cholesterol from
the plasma membrane has an additional, equally impor-
tant effect, which is crucial for virus survival. WNV infec-
tion causes disruption of cholesterol-dependent surface
domains, and this inactivates the IFN-regulated Jak/Stat
signaling pathway, as demonstrated by the rescue of
signaling by cholesterol addition to infected cells. Thus,
the redistribution of intracellular cholesterol to sites of
WNV RNA replication appears to play a key regulatory
role in the dissociation of lipid raft formation and function,
culminating in the loss of ability of infected cells to236 Cell Host & Microbe 2, 229–239, October 2007 ª2007 Elsevierespond to IFN and to restrict viral replication. This is
exemplified by the increased ability of infected cells to
activate IFN signaling upon incubation with exogenous
cholesterol (Figure 6). In this situation plasma membrane
concentrations of cholesterol have been restored (Fig-
ure 5E), enabling the recruitment and activation of the
IFN receptor and associated signaling molecules. This is
also accentuated by the reduction in virus replication
presumably due to the dissolution of the membranous
replication complex (Figure 3). These observations have
fundamental importance for understanding virus-cell
interactions with potential therapeutic implications. WNV
has exploited the complex machinery involved in cellular
cholesterol regulation to serve its own replication needs,
while utilizing the same cholesterol-based mechanism to
inactivate surface signaling domains. Compounds that
target cholesterol biosynthesis and/or HMGCR activity
may provide candidate antiviral treatments to combatr Inc.
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Modulation of Cholesterol by Flavivirusesthis pathogenic family of viruses. Cotreatment of WNV-
infected patients with Lov and cholesterol could provide
a safe and low-cost application for future clinical trials.
EXPERIMENTAL PROCEDURES
Viruses and Cells
Vero cells were grown and maintained in DMEMmedium (GIBCO BRL)
supplemented with 5% fetal calf serum and penicillin/streptomycin.
Cells were infected with WNVKUN strain MRM61C or WNVNY99 at a
multiplicity of infection (moi) of 5, as previously described (Westaway
et al., 1997), and infected cells were maintained in DMEM medium
containing 0.1% bovine serum albumin (BSA; Sigma Aldrich, St. Louis,
MO).
Reagents
Antibodies
WNV-specific anti-NS1 (clone 4G4; Macdonald et al., 2005) monoclo-
nal antibodies and guinea pig anti-dsRNA antibodies have been
described previously (Magliano et al., 1998). Mouse monoclonal anti-
NS5 (clone 5H1.1) antibodies were generously provided by Dr. Roy
Hall (university of Queensland, Brisbane, Australia). Rabbit anti-
HMGCR antibodies were generously provided by Dr. Peter Edwards
(UCLA, CA). Anti-Caveolin-1, anti-phosphorylated-Stat-1 antibody
(clone 550428), and rabbit anti-actin antibodies were purchased
from PharMingen (San Diego, CA) and Sigma Aldrich (St. Louis, MO)
respectively. Anti-rabbit- and anti-mouse-specific IgG Oregon green,
Texas red, and horseradish peroxidase were purchased from Molecu-
lar Probes (Invitrogen, Leiden, The Netherlands).
Chemicals
Filipin compound, Lov, methyl-b-cyclodextran, 25-hydroxycholese-
trol, cyclodextran complexed cholesterol, geranylgeranylation inhibi-
tor GGTI-298, farnesylation inhibitor B2559 B581 (FPTI), AY-9944,
and DAPI were all purchased from Sigma Aldrich (St. Louis, MO).
IF Analysis
Vero cell monolayers on coverslips were infected with WNV at approx-
imately 3–5 moi and incubated at 37C for 24 hr. The cells were sub-
sequently washed with PBS and fixed with 4% paraformaldehyde
(Sigma Aldrich, St. Louis, MO) for 10 min at 20C and permeabilized
with 0.1% Triton X-100 in 4% paraformaldehyde for an additional
10 min at 20C; the cells were washed with PBS, and aldehyde groups
were quenched with 0.2 M glycine in PBS and additionally washed
twice with PBS before incubation with antibodies. Primary and sec-
Figure 6. Addition of Cholesterol Enhances the Ability of IFN
to Restrict WNVKUN Replication
Quantification of the observed effects of increasing concentrations of
IFN-a on WNVKUN RNA replication in A549 cells, in the absence or
presence of cholesterol, was assessed after two independent experi-
ments performed in triplicate. A significant shift in the ability of IFN-a to
restrict WNVKUN replication was observed in the presence of choles-
terol (*p < 0.05, Student’s t test).Cell Hosondary antibodies were incubated within blocking buffer (PBS contain-
ing 1% BSA) and washed with PBS containing 0.1% BSA between
incubation steps. After a final wash with PBS, the coverslips were
drained and mounted onto glass slides with a quick-dry mounting me-
dium (United Biosciences, Brisbane, Australia) before visualization on
a Zeiss Axiophot 2 IFmicroscope. Images were collected using a Zeiss
AxioCam MRm digital camera and Axiovision AC software before
processing for publication using Adobe Photoshop software.
Western Blotting
WNVKUN-infected or uninfected cells were lysed in 13 SDS-PAGE
loading buffer, and proteins were separated on 10% polyacrylamide-
SDS gels. Then proteins were subsequently transferred to an
Hybond-ECL nitrocellulose membrane (Amersham Biosciences
Corp., Piscataway, NJ) using the BioRad wet-transfer blotting module.
The membrane was subsequently blocked with 5% Skim Milk Powder
(Diploma) in PBS containing 0.1% Tween-20 at room temperature.
Incubation with the appropriate antibodies was performed in blocking
buffer on a rotating wheel overnight at 4C. The bound antibodies were
subsequently visualized with species-specific IgG conjugated to
horseradish peroxidase and the ECL Plus chemiluminescence kit
(Amersham Biosciences Corp.) by exposure to X-ray film or by detec-
tion and visualization using species-specific Alexa Fluor 680 (Molecu-
lar Probes) or IRDye 800CW (Rockland Incorporated)-conjugated IgG
antibodies and the LI-COR Odyssey scanner. The resulting images
were digitally scanned and processed in Adobe Photoshop for
publication.
Electron Microscopy
Methods for resin embedding, cryofixation, preparation of cryosec-
tions, and immunolabeling have been described elsewhere (Macken-
zie et al., 1996a, 1996b; Westaway et al., 1997). Briefly, WNV-infected
cells were fixed with 4%paraformaldehyde/0.1%glutaraldehyde (Pro-
SciTech, Kirwan, Australia) in PBS on ice for 60 min and subsequently
embedded within a 10% gelatin block before postfixing with 1% para-
formaldehyde in PBS. The sample blocks were infused with a mixture
of sucrose and polyvinylpyrrolidone and mounted onto cryostubs
(Leica) for cryosectioning. Ultrathin cryosections (55 nm) were cut
with a Diatome Cryo-P diamond knife and retrieved from the cryo-
chamber with a droplet of 14:1 2.3 M sucrose/2% methylcellulose.
The recovered sections were subsequently immunolabeled with the
appropriate antibodies and protein-A gold conjugated to 10 nm gold
and contrasted with 1.8 M methylcellulose containing 0.4% uranyl
acetate. The sections were then viewed on JOEL 1010 transmission
electron microscope, and images were captured on a MegaView III
side-mounted CCD camera (Soft Imaging Systems, USA) and
processed for publication in Adobe Photoshop.
Chemical Treatments and Reporter Assay
Vero cells in quadruplicate in 96-well plates were infected with virus-
like particles encapsulating WNVKUN replicon RNA encoding for the
b-galactosidase (b-gal) gene (Harvey et al., 2004; Liu et al., 2002) at
an moi of 5. After the initial infection period of 90 min at 37C, the
inoculum was removed and replaced with DMEM containing 0.1%
BSA and the corresponding chemicals to the following final concentra-
tions: Lov, 10 or 100 mM; M-b-CD, 8 mg/ml in media; CD-cholesterol,
10 mg/ml; 25-hydroxycholesterol, 10 mg/ml; AY-9944, 1 mM; GGTI-
298, 10 mM; FPTI, 10 mM; geranyl- and farnesyl-phosphate; 10 mM.
The infected cells were then harvested at 48 hr p.i., and detection
and quantitation of replicon replication were performed by b-Gal assay
of lysed cells using a b-galactosidase enzyme assay kit (Promega,
Madison, WI) essentially as described by the manufacturer. Effects
on IFN signaling were assessed as above except Vero cells were
only transfected with an IFN-a/b-responsive (ISRE) luciferase reporter
plasmid p(9-27)4thD (39)Lucter (King and Goodbourn, 1994). Thirty-
six hours after transfection, cells were incubated with filipin and/or CD-
cholesterol for 60min before stimulation with 1000 U of IFN-aA (I-4276;
Sigma) per ml for an additional 14 hr before lysis within luciferaset & Microbe 2, 229–239, October 2007 ª2007 Elsevier Inc. 237
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Modulation of Cholesterol by Flavivirusesreporter assay buffer (Promega, Madison, WI) and analysis of lucifer-
ase expression.
RNAi-Mediated Knockdown of HMGCR
For HMGCR gene silencing, Vero cells were transfected for 24 hr with
200 pmol of Stealth RNAi specific for human HMGCR purchased from
Invitrogen. The transfected cells were then infected with virus-like par-
ticles encapsulating WNVKUN replicon RNA encoding for the b-gal
gene at a moi of 5. A cocktail of three RNAi duplexes were used for
transfection using Lipofectamine 2000, and the transfections occurred
every 24 hr until 48 hr postinfection. Transfected cells were subse-
quently harvested in Promega Reporter lysis buffer for analysis of b-
galactosidase expression and for western blot analysis of HMGCR
expression, as described above. A medium G-C content RNAi duplex
was purchased from Invitrogen and used as a control.
Sucrose Flotation Gradients
Separation of detergent resistant membranes was performed accord-
ing to Fra et al. (1994). WNVKUN-infected Vero cells were lysed with
TNE buffer (25 mM Tris-HCl [pH 7.5], 150 mM NaCl, 5 mM EDTA)
containing 1% Triton X-100 and protease inhibitors (PMSF, aprotinin,
and leupeptin). Insoluble material was removed by centrifugation,
and the resulting supernatant was equilibrated to 1.5 M sucrose and
overlaid with volumes of 1.8 M and 0.15 M sucrose. The DRMs were
separated by centrifugation in a SW41Ti rotor (Beckman Coulter) at
38,000 rpm for 18 hr at 4C. One milliliter fractions were collected
from the top and analyzed by SDS-PAGE and western blotting using
anti-Caveolin-1 and anti-NS5 antibodies.
IFN Sensitivity Assay
A549 cells grown in 96-well plates were infected with virus-like parti-
cles encapsulating WNVKUN replicon RNA encoding for the b-galacto-
sidase (b-gal) gene (Harvey et al., 2004; Liu et al., 2002) at an moi of 5.
After the initial infection period of 90 min at 37C, the inoculum was
removed and replaced with DMEM/F12 media containing 2% fetal
calf serum in the presence or absence of 10 mg/ml CD-cholesterol.
At 6 hr p.i., increasing amounts of IFN-a were added to the medium.
The infected cells were subsequently harvested at 48 hr p.i., and
detection and quantitation of replicon replication were performed by
b-Gal assay of lysed cells using a b-galactosidase enzyme assay kit
(Promega, Madison, WI) essentially as described by the manufacturer.
Supplemental Data
The Supplemental Data include Supplemental Results and Experi-
mental Procedures, one supplemental table, and two supplemental
figures and can be found with this article online at http://www.
cellhostandmicrobe.com/cgi/content/full/2/4/229/DC1/.
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